Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Merante
S
S
Colombo
A A
AA
Calatroni
S
S
Rocca
B
B
Boni
M
M
Bernasconi
P
P
Bonvini
L
L
Soverini
S
S
Alessandrino
E P
EP
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000601:surgery / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D014019:Tissue Donors; D018183:Transplantation Chimera
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate